TY - JOUR
T1 - Two-year trajectories of COVID-19 symptoms and their association with illness perception
T2 - A prospective cohort study in Amsterdam, the Netherlands
AU - Wynberg, Elke
AU - Verveen, Anouk
AU - van Willigen, Hugo D. G.
AU - Nieuwkerk, Pythia
AU - Davidovich, Udi
AU - Lok, Anja
AU - de Jong, Menno D.
AU - de Bree, Godelieve J.
AU - Leenstra, Tjalling
AU - Knoop, Hans
AU - Prins, Maria
AU - Boyd, Anders
AU - Agard, Ivette
AU - Ayal, Jane
AU - Cavdar, Floor
AU - Craanen, Marianne
AU - Deuring, Annemarieke
AU - van Dijk, Annelies
AU - Dijkstra, Maartje
AU - Ersan, Ertan
AU - del Grande, Laura
AU - Hartman, Joost
AU - Koedoot, Nelleke
AU - Lebbink, Romy
AU - Loomans, Dominique
AU - Makowska, Agata
AU - du Maine, Tom
AU - de Man, Ilja
AU - Matser, Amy
AU - van der Meij, Lizenka
AU - van Polanen, Marleen
AU - Oud, Maria
AU - Reid, Clark
AU - Storey, Leeann
AU - van Wijk, Marc
AU - van den Aardweg, Joost
AU - van Assem, Joyce
AU - van Beek, Marijne
AU - Figaroa, Orlane
AU - Frenkel, Leah
AU - van Gils, Marit
AU - Han, Xiaochuan
AU - Harskamp-Holwerda, Agnes
AU - Hazenberg, Mette
AU - Hidad, Soemeja
AU - de Jong, Nina
AU - Kootstra, Neeltje
AU - Kuijt, Lara
AU - Moll van Charante, Eric P.
AU - Russell, Colin
AU - van der Straten, Karlijn
AU - van der Veen, Annelou
AU - Verkaik, Bas
AU - Visser, Gerben-Rienk
AU - RECoVERED Study Group
N1 - Funding Information: The authors wish to thank all RECoVERED study participants. We would also like specifically acknowledge Dr. Eric Moll van Charante for helping to plan the psychosocial analyses within the RECoVERED cohort. Publisher Copyright: © 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Background: We used data from a prospective cohort to explore 2-year trajectories of ‘long COVID’ (persistent symptoms after SARS-CoV-2 infection) and their association with illness perception. Methods: RECoVERED participants (adults; prospectively enrolled following laboratory-confirmed SARS-CoV-2 infection, May 2020–June 2021) completed symptom questionnaires at months 2–12, 18 and 24, and the Brief Illness Perception Questionnaire (B-IPQ) at months 1, 6 and 12. Using group-based trajectory models (GBTM), we modelled symptoms (mean total numbers and proportion with four specific complaints), including age, sex, BMI and timing of infection as covariates. In a multivariable linear mixed-effects model, we assessed the association between symptom trajectories and repeated B-IPQ scores. Results: Among 292 participants (42% female; median age 51 [IQR = 36–62]), four trajectories were identified, ranging from Trajectory 4 (8.9%; 6 + symptoms) to Trajectory 1 (24.8%; no symptoms). The occurrence of fatigue and myalgia increased among 23% and 12% of participants, respectively. Individuals in Trajectory 4 experienced more negative adjusted B-IPQ scores over time than those in Trajectories 1–3. Conclusions: We observed little fluctuation in the total number of symptoms, but individual symptoms may develop as others resolve. Reporting a greater number of symptoms was congruent with more negative illness perception over time.
AB - Background: We used data from a prospective cohort to explore 2-year trajectories of ‘long COVID’ (persistent symptoms after SARS-CoV-2 infection) and their association with illness perception. Methods: RECoVERED participants (adults; prospectively enrolled following laboratory-confirmed SARS-CoV-2 infection, May 2020–June 2021) completed symptom questionnaires at months 2–12, 18 and 24, and the Brief Illness Perception Questionnaire (B-IPQ) at months 1, 6 and 12. Using group-based trajectory models (GBTM), we modelled symptoms (mean total numbers and proportion with four specific complaints), including age, sex, BMI and timing of infection as covariates. In a multivariable linear mixed-effects model, we assessed the association between symptom trajectories and repeated B-IPQ scores. Results: Among 292 participants (42% female; median age 51 [IQR = 36–62]), four trajectories were identified, ranging from Trajectory 4 (8.9%; 6 + symptoms) to Trajectory 1 (24.8%; no symptoms). The occurrence of fatigue and myalgia increased among 23% and 12% of participants, respectively. Individuals in Trajectory 4 experienced more negative adjusted B-IPQ scores over time than those in Trajectories 1–3. Conclusions: We observed little fluctuation in the total number of symptoms, but individual symptoms may develop as others resolve. Reporting a greater number of symptoms was congruent with more negative illness perception over time.
KW - Adult
KW - COVID-19
KW - COVID-19/epidemiology
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Netherlands/epidemiology
KW - Perception
KW - Prospective Studies
KW - SARS-CoV-2
KW - Surveys and Questionnaires
KW - illness perception
KW - sequelae
KW - symptoms
KW - trajectories
UR - http://www.scopus.com/inward/record.url?scp=85173020635&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/irv.13190
DO - https://doi.org/10.1111/irv.13190
M3 - Article
C2 - 37789876
SN - 1750-2640
VL - 17
SP - e13190
JO - Influenza and other respiratory viruses
JF - Influenza and other respiratory viruses
IS - 10
M1 - e13190
ER -